
- Volume 0 0
Gastric Bypass Lowers Risk for Heart Disease
A study from Stanford University determined that gastric bypass surgery for the treatment of obesity lowers the risk of heart disease even more than previously reported. Using 3 measures to determine heart disease risk?C-reactive protein, lipoprotein A, and homocysteine?as well as cholesterol levels, researchers studied 371 patients pre-and postsurgery. Patients showed improvements to normal range in all measures.
John Morton, MD, MPH, MHA, assistant professor of surgery at Stanford, said that using statins, considered the most effective nonsurgical treatment for heart disease, lowers C-reactive protein by ~16%. "We found that gastric bypass lowered it by 50%," he said. Gastric bypass surgery, reduces the size of the stomach so that patients have to eat less, and it also removes a long stretch of small intestine so that fewer nutrients are absorbed.
Ms. Farley is a freelance medical writer based in Wakefield, RI.
Articles in this issue
over 20 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsover 20 years ago
Dangerous Liaisons: Schizophrenia and Diabetesover 20 years ago
Tarceva Extends Lung Cancer Survivalover 20 years ago
Inhaled Morphine Aids Cancer-related Dyspneaover 20 years ago
Diuretic Best BP Therapy for African Americansover 20 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsover 20 years ago
New Drug Blocks Out AIDS Virusover 20 years ago
Viagra Ingredient Has Another Useover 20 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIANewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























